BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 3213226)

  • 21. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymphocytic infiltration in thyroid neoplasms. Preliminary prognostic assessments].
    Mancini A; Rabitti C; Conte G; Gullotta G; De Marinis L
    Minerva Chir; 1993 Nov; 48(21-22):1283-8. PubMed ID: 8152558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is the new WHO's histological typing clinically useful for the diagnosis of follicular cancer of the thyroid?].
    Takaya K; Masuda T; Mori Y; Matsumoto M; Iguchi A; Mori S
    Nihon Geka Gakkai Zasshi; 1991 Nov; 92(11):1636-41. PubMed ID: 1770936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Problem areas of tumour classifications--thyroid carcinomas].
    Schmid KW
    Verh Dtsch Ges Pathol; 2007; 91():57-65. PubMed ID: 18314596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study.
    Basolo F; Pollina L; Pacini F; Fontanini G; Ménard S; Castronovo V; Bevilacqua G
    Clin Cancer Res; 1996 Oct; 2(10):1777-80. PubMed ID: 9816129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The biological classifications of malignant thyroid tumours (author's transl)].
    Kokoschka R; Roka R; Depisch D; Aiginger P; Weissel M; Kolbe H; Krisch K
    Wien Klin Wochenschr; 1979 Sep; 91(18):605-10. PubMed ID: 483824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular carcinoma.
    Franssila KO; Ackerman LV; Brown CL; Hedinger CE
    Semin Diagn Pathol; 1985 May; 2(2):101-22. PubMed ID: 3843689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular variant of papillary thyroid carcinoma: a long-term follow-up.
    Passler C; Prager G; Scheuba C; Niederle BE; Kaserer K; Zettinig G; Niederle B
    Arch Surg; 2003 Dec; 138(12):1362-6. PubMed ID: 14662540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].
    Schröder S; Dralle H; Bay V; Böcker W
    Acta Med Austriaca; 1989; 16(1):2-5. PubMed ID: 2711816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in medullary thyroid carcinomas.
    Schröder S; Dralle H
    Horm Metab Res Suppl; 1989; 21():26-8. PubMed ID: 2807152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary thyroid microcarcinoma: clinical study and prognosis.
    Rodriguez JM; Moreno A; Parrilla P; Sola J; Soria T; Tebar FJ; Aranda F
    Eur J Surg; 1997 Apr; 163(4):255-9. PubMed ID: 9161822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases.
    Mihailovic JM; Stefanovic LJ; Malesevic MD; Erak MD; Tesanovic DD
    Nucl Med Commun; 2009 Jul; 30(7):558-64. PubMed ID: 19436230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
    Lukács G; Balázs G; Zs-Nagy I; Juhász F
    Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.